Terms: = Head and neck cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Prognosis
10 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
Dal Bo M; Polano M; Ius T; Di Cintio F; Mondello A; Manini I; Pegolo E; Cesselli D; Di Loreto C; Skrap M; Toffoli G
J Transl Med; 2023 Jul; 21(1):450. PubMed ID: 37420248
[TBL] [Abstract] [Full Text] [Related]
3. Investigating survival, quality of life and cognition in PROton versus photon therapy for
Heggebø LC; Borgen IMH; Rylander H; Kiserud C; Nordenmark TH; Hellebust TP; Evensen ME; Gustavsson M; Ramberg C; Sprauten M; Magelssen H; Blakstad H; Moorthy J; Andersson K; Raunert I; Henry T; Moe C; Granlund C; Goplen D; Brekke J; Johannessen TA; Solheim TS; Marienhagen K; Humberset Ø; Bergström P; Agrup M; Dahl L; Gubanski M; Gojon H; Brahme CJ; Rydén I; Jakola AS; Vik-Mo EO; Lie HC; Asphaug L; Hervani M; Kristensen I; Rueegg CS; Olsen IC; Ledal RJ; Degsell E; Werlenius K; Blomstrand M; Brandal P
BMJ Open; 2023 Mar; 13(3):e070071. PubMed ID: 36940951
[TBL] [Abstract] [Full Text] [Related]
4. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.
Wang F; Zhao F; Zhang L; Xiong L; Mao Q; Liu Y; Qiu X; Wang X; Shui L; Chen X; Ren K; Shui P; Zhang Q; Deng Y; Li W; Xie X; Wu D; Li T; Lang J; Liu L; Chen H; Xu J; Bai S; Li Z; Yue Q; Chen N; Zhou B; Yi C; Wei Y; Fu Y; Luo Y; Gou Q; Liu L; Liu Y; Kang J; Wang J; Jing D; Zhang F; Yang X; Li X; Jiang T; Zhang Z; Zhou Y; Yi J
Mol Cancer; 2022 Jul; 21(1):153. PubMed ID: 35879762
[TBL] [Abstract] [Full Text] [Related]
5. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
Lang Kuhs KA; Faden DL; Chen L; Smith DK; Pinheiro M; Wood CB; Davis S; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Wang X; Liu P; Mehrad M; Tucker T; Lewis JS; Ferris RL; Mirabello L
Ann Oncol; 2022 Jun; 33(6):638-648. PubMed ID: 35306154
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic Features and prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations.
Wu L; An J; Liu H
World Neurosurg; 2022 Mar; 159():e23-e31. PubMed ID: 34856401
[TBL] [Abstract] [Full Text] [Related]
7. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
[TBL] [Abstract] [Full Text] [Related]
8. Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Zhang B; Li Q; Wu B; Zhang S; Li L; Jin K; Li S; Li K; Wang Z; Lu Y; Xia L; Sun C
Aging (Albany NY); 2021 Feb; 13(4):5638-5649. PubMed ID: 33589576
[TBL] [Abstract] [Full Text] [Related]
9. Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients.
Woo PYM; Lee JWY; Lam SW; Pu JKS; Chan DTM; Mak CHK; Ho JMK; Wong ST; Po YC; Lee MWY; Chan KY; Poon WS
Br J Neurosurg; 2024 Apr; 38(2):385-392. PubMed ID: 33576706
[TBL] [Abstract] [Full Text] [Related]
10. PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (idh) Mutations.
Röver LK; Gevensleben H; Dietrich J; Bootz F; Landsberg J; Goltz D; Dietrich D
EBioMedicine; 2018 Feb; 28():97-104. PubMed ID: 29396294
[TBL] [Abstract] [Full Text] [Related]